Advancing core workflows with the Intabio ZT system
Advancing core workflows with the Intabio ZT system
Advancing core workflows with the Intabio ZT system
Event Overview:
Thu, Nov 7, 2024 11:00 AM EDT
Characterization of charge isoforms, whether in early product development or associated with licensure filings, is usually achieved through separate analytical techniques. Fraction collection via ion-exchange (IEX) liquid chromatography or iCE followed by mass spectrometry are typically used.
This webinar discusses opportunities to advance core platform technologies through a fully integrated icIEF-UV/MS workflow on the Intabio ZT system and how rapid post-translational modification (PTM) characterization of charge isoforms can be used to guide decisions during early development.
Key Learning Objectives:
• Identify sequence variants with icIEF-UV/MS
• Identify charge variants of AAVs with icIEF-UV/MS
• Incorporate icIEF-UV/MS into existing standard operating procedures
• Understand the impact rapid charge variant identification has on drug development
Who Should Attend:
• Analytical development scientists
• Process development scientists
• Cell line development scientists
• Protein characterization scientists
Featured Speakers
Kristen Nields, PhD
Principal Scientist
Johnson & Johnson Innovative Medicine
Xiaoping He, PhD
Principal Scientist
Pfizer
For any technical questions please contact David Ambrose: Dambrose@mjhlifesciences.com